Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195, USA.
Blood. 2010 Sep 16;116(11):1932-41. doi: 10.1182/blood-2010-02-268508. Epub 2010 May 27.
Hypercholesterolemia is associated with increased platelet sensitivity to agonists and a prothrombotic phenotype. Mechanisms of platelet hypersensitivity are poorly understood; however, increased platelet cholesterol levels associated with hypercholesterolemia were proposed as leading to hypersensitivity. Scavenger receptor class B type I (SR-BI) in the liver controls plasma high-density lipoprotein (HDL) levels, and SR-BI-deficient mice display a profound dyslipoproteinemia. SR-BI is also expressed on platelets, and recent studies have suggested a role for SR-BI in platelet function; however, its role in hemostasis is unknown. Our present studies demonstrated that non-bone marrow-derived SR-BI deficiency and the dyslipidemia associated with it lead to platelet hyperreactivity that was mechanistically linked to increased platelet cholesterol content. Platelet-specific deficiency of SR-BI, on the other hand, was associated with resistance to hyperreactivity induced by increased platelet cholesterol content. Intravital thrombosis studies demonstrated that platelet SR-BI deficiency protected mice from prothrombotic phenotype in 2 types of dyslipidemia associated with increased platelet cholesterol content. These novel findings demonstrate that SR-BI plays dual roles in thrombosis and may contribute to acute cardiovascular events in vivo in hypercholesterolemia.
高胆固醇血症与血小板对激动剂的敏感性增加和促血栓形成表型有关。血小板高敏感性的机制尚未完全阐明;然而,与高胆固醇血症相关的血小板胆固醇水平升高被认为是导致高敏感性的原因。肝脏中的清道夫受体 B 型 I 类(SR-BI)控制血浆高密度脂蛋白(HDL)水平,而 SR-BI 缺陷型小鼠则表现出严重的脂蛋白血症。SR-BI 也在血小板上表达,最近的研究表明 SR-BI 在血小板功能中起作用;然而,其在止血中的作用尚不清楚。我们目前的研究表明,非骨髓来源的 SR-BI 缺乏症及其相关的血脂异常导致血小板高反应性,其机制与血小板胆固醇含量增加有关。另一方面,血小板特异性的 SR-BI 缺乏与由增加的血小板胆固醇含量引起的高反应性诱导的抗性有关。活体血栓形成研究表明,血小板 SR-BI 缺乏可保护小鼠免受与血小板胆固醇含量增加相关的 2 种类型的促血栓形成表型的影响。这些新发现表明,SR-BI 在血栓形成中起双重作用,并可能导致体内高胆固醇血症中的急性心血管事件。